FluoroPharma Medical, Inc. (FPMI)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Dec 22, 2025
FluoroPharma Medical Market Cap
FluoroPharma Medical has a market cap or net worth of $5.52 thousand as of January 23, 2026. Its market cap has decreased by -92.39% in one year.
Market Cap
5.52K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 17, 2011, FluoroPharma Medical's market cap has decreased from 24.55M to 5.52K, a decrease of -99.98%. That is a compound annual growth rate of -43.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 5.52K | 99.96% |
| Dec 23, 2024 | 2.76K | - |
| Dec 14, 2023 | 2.76K | -94.67% |
| Dec 27, 2022 | 51.74K | 152,064.71% |
| Dec 29, 2021 | 34.00 | -99.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Statera Biopharma | 7.26K |
| Therapeutic Solutions International | 7.05K |
| NovAccess Global | 6.19K |
| Theralink Technologies | 6.15K |
| Hard to Treat Diseases | 5.82K |
| Better Therapeutics | 5.45K |
| Syros Pharmaceuticals | 5.37K |
| MultiCell Technologies | 5.00K |